Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ABBOTT LABORATORIES T.ABT


Primary Symbol: ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.


NYSE:ABT - Post by User

Comment by Capharnaumon Mar 19, 2022 10:51am
231 Views
Post# 34527734

RE:RE:Any news?

RE:RE:Any news?
NLMoose wrote:

Number one reason is that Absolute Software is mismanaged.

While Absolute Software's sales continue to increase, they are still losing money due to excessive spending and mismanagement.

If Absolute Software was well managed, they would make a profit as opposed to incurring losses each quarter.

I think that Absolute Software's Board of Directors, including Christy Wyatt, Daniel Ryan, Lynn Atchison, Andre Mintz, Gregory Monahan, Sal Visca, and Gerhard Watzinger need to be recalled to address concerns about the company's financial management.

If that was the reason though, why would the price have shot up by 20% after their latest financials? This isn't a "new item" that was discovered last Friday afternoon (-6%).

I'm okay with the numbers they published when the share price is under $10, but was wondering if something else than reported numbers might be pushing down the price.

<< Previous
Bullboard Posts
Next >>